Next-Generation Tungsten-Based Honeycomb Direction Modulated Brachytherapy (DMBT) Tandem Applicator for GYN Brachytherapy: Extending and Surpassing the (DMBT) Six-Groove Tandem Applicator Benchmark
Abstract
Purpose
Directional Modulated Brachytherapy (DMBT) tandems using tungsten shielding have demonstrated improved dose conformity versus conventional tandem-and-ring (T&R) applicators. In prior work, DMBT six-groove tandem with a standard ring reduced D2cc to rectum, bladder, and sigmoid by up to 20.1%, 32.4%, and 19.7%, respectively, relative to T&R intracavitary plans, while maintaining equivalent target coverage. However, that design was limited to a single primary directional pattern. We developed a next-generation “Honeycomb” tandem to generalize the DMBT concept, enabling a broader family of dose distributions for complex gynecological targets while maintaining or exceeding six-groove performance.
Methods
Honeycomb tandem consists of a 6.5 mm diameter MR-compatible tungsten alloy base with 19 channels in a honeycomb pattern, accommodating up to 18 deployable 192Ir wires for directionally modulated HDR delivery. The previously studied DMBT tandem served as a quantitative performance benchmark. GEANT4 Monte Carlo simulations were used to evaluate Honeycomb-based dose distributions in representative cervical and endometrial scenarios. Channel activation and dwell patterns were optimized to emulate or extend conventional T&O, Y-type, and six-groove DMBT dose distributions. Isodose patterns were compared qualitatively, with representative cases assessed for target coverage and vaginal dose.
Results
The tungsten Honeycomb tandem reproduced the pear-shaped distribution of conventional T&R and the directional pattern of the DMBT six-groove design while providing substantially greater flexibility. In asymmetric cases, Honeycomb achieved approximately 1 cm increased lateral reach of clinically relevant isodose lines without interstitial needles. Configurations supporting partial-volume “half-pear” boosts enabled focal coverage of residual subvolumes. In a representative case, sculpting away from the vagina and de-escalation of ovoid-equivalent dose produced approximately 22% reduction in vaginal dose while maintaining target coverage in simulation.
Conclusion
The Honeycomb DMBT tandem extends and surpasses the capabilities of the earlier DMBT six-groove design, providing a versatile, minimally invasive, MR-compatible platform with enhanced dose-shaping flexibility for GYN brachytherapy.